Durham, NC, United States · North America
100sterile
OncologyRare diseaseCell & gene therapyVaccines
FDAEMAPMDANMPA
SCALE 270 studies
Loading…
Clinical Development
CROs
Clinical research organizations38
CROs listed
Trial management, monitoring, biostatistics and data services — scored on real operational depth, not sales polish.
Scores are deterministic, rules-based — not AI.
OncologyVaccinesRare disease
NMPAFDAEMAPMDA
SCALE 270 studies
OncologyVaccines
PMDAFDAEMANMPA
SCALE 270 studies
OncologyInfectious diseaseVaccines
FDAEMAMHRAHealth Canada
SCALE 270 studies
Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 270 studies